-
ORKA Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Oruka Therapeutics (ORKA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 410.88 mm | 410.88 mm | 410.88 mm | 410.88 mm | 410.88 mm | 410.88 mm |
Cash burn (monthly) | (no burn) | (no burn) | 9.82 mm | 3.05 mm | (no burn) | 434.08 k |
Cash used (since last report) | n/a | n/a | 39.48 mm | 12.28 mm | n/a | 1.75 mm |
Cash remaining | n/a | n/a | 371.39 mm | 398.59 mm | n/a | 409.13 mm |
Runway (months of cash) | n/a | n/a | 37.8 | 130.5 | n/a | 942.5 |
13F holders | Current |
---|---|
Total holders | 23 |
Opened positions | 23 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 262.10 bn |
Total shares | 18.54 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Fairmount Funds Management | 7.94 mm | $192.03 mm |
FMR | 4.68 mm | $114.76 bn |
RTW Investments | 1.85 mm | $45.36 bn |
Deep Track Capital | 1.24 mm | $30.27 bn |
BEN Franklin Resources | 720.55 k | $19.99 bn |
Great Point Partners | 514.66 k | $12.61 bn |
SR One Capital Management | 375.33 k | $9.20 bn |
Affinity Asset Advisors | 349.84 k | $8.57 bn |
JHG Janus Henderson | 236.12 k | $5.84 bn |
Adage Capital Partners GP, L.L.C. | 200.00 k | $4.90 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Jan 25 | Klein Lawrence Otto | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 12.5 | 230,000 | 2.88 mm | 230,000 |
22 Jan 25 | Goncalves Joana | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 12.5 | 162,500 | 2.03 mm | 162,500 |
22 Jan 25 | Paul T Quinlan | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 12.5 | 162,500 | 2.03 mm | 162,500 |
22 Jan 25 | Arjun Agarwal | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 12.5 | 120,000 | 1.50 mm | 120,000 |
19 Nov 24 | Fairmount Funds Management | Common Stock | Option exercise | Acquire M | Yes | No | 0 | 160,000 | 0.00 | 798,614 |
19 Nov 24 | Fairmount Funds Management | Series A Non-Voting Convertible Preferred Stock Common Stock | Option exercise | Dispose M | Yes | No | 0 | 160 | 0.00 | 0 |